GLP-1 receptor agonists, a diabetic medication may help in reducing alcohol consumption and alcohol-related health problems.

More than 48 million Americans 12 years or older had a substance use disorder in 2022, yet only 24 percent received treatment ...

It’s hard to remember a time before Ozempic, Wegovy, and other injectable drugs referred to as GLP-1 receptor agonists (that ...

GLP-1 Receptor Agonist medications, such as Ozempic, combined with exercise and nutrition, can help reduce obesity, according ...

Effective treatments for alcohol dependence exist; however, they remain underused and are not effective, or suitable, for all ...

Tirzepatide shows promise in reducing weight and preventing diabetes progression in people with obesity and prediabetes, with ...

New research, led by experts at the University of Nottingham, has found that certain types of medication used to treat ...

It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

Metsera has brought in over $500m in funding in just seven months as it looks to enter the competitive weight loss arena.

For the third quarter of 2024, Ascendis Pharma reported a net loss of €99.2 million, or €1.72 per share (basic and diluted) ...

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...